FRACTYL HEALTH CFO buys 20,000 GUTS shares

FRACTYL HEALTH, INC.

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. Chief Financial Officer Lara Smith Weber reported an open-market purchase of 20,000 shares of common stock. The shares were bought on June 8, 2026 at a weighted average price of $0.6854 per share, in multiple trades between $0.6844 and $0.6896. Following this transaction, she directly owns 20,000 common shares.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 1 txn

Insider Smith Weber Lara

Role Chief Financial Officer

Bought 20,000 shs ($14K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,000	$0.6854	$14K

Holdings After Transaction: Common Stock — 20,000 shares (Direct)

Footnotes (2)

1. F1. Open market purchase.
2. F2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6844 to $0.6896, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Key Figures

Shares purchased: 20,000 shares Weighted average price: $0.6854 per share Price range: $0.6844–$0.6896 per share +2 more

5 metrics

Shares purchased 20,000 shares Open-market purchase on June 8, 2026

Weighted average price $0.6854 per share Common stock purchase

Price range $0.6844–$0.6896 per share Range of individual trade prices

Shares owned after transaction 20,000 shares Direct ownership following purchase

Net buy shares 20,000 shares Net buy direction in transaction summary

Key Terms

open-market purchase, weighted average price, transaction code P, Form 4

4 terms

open-market purchase financial

"Open market purchase."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

transaction code P regulatory

"transaction_code": "P","transaction_code_description": "Purchase in open market or private transaction""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FRACTYL HEALTH (GUTS) disclose in this Form 4?

FRACTYL HEALTH reported that its Chief Financial Officer, Lara Smith Weber, bought 20,000 shares of common stock. The transaction was an open-market purchase on June 8, 2026, and reflects her direct ownership position after the trade.

How many FRACTYL HEALTH (GUTS) shares did the CFO buy and at what price?

The CFO purchased 20,000 FRACTYL HEALTH common shares at a weighted average price of $0.6854 per share. The shares were acquired in multiple trades within a narrow range between $0.6844 and $0.6896.

What type of transaction is reported for FRACTYL HEALTH (GUTS) in this Form 4?

The filing shows an open-market purchase of common stock by the CFO. It is classified under transaction code P, which indicates a purchase in the open market or a private transaction under SEC rules.

What is the CFO’s FRACTYL HEALTH (GUTS) share ownership after this transaction?

After the reported purchase, the CFO directly owns 20,000 shares of FRACTYL HEALTH common stock. This figure represents her direct holding following the June 8, 2026 open-market acquisition disclosed in the Form 4.

Did the FRACTYL HEALTH (GUTS) Form 4 mention a price range for the trades?

Yes. The Form 4 notes that the 20,000 shares were bought in multiple transactions, with prices ranging from $0.6844 to $0.6896 per share. The reported $0.6854 figure is the weighted average purchase price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 06:55 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Weber Lara

(Last) (First) (Middle)

3 VAN DE GRAAFF DRIVE SUITE 200

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/08/2026		P(1)		20,000	A	$0.6854(2)	20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Open market purchase.

2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6844 to $0.6896, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)